Blue Clay Capital Management’s Enzo Biochem, Inc. ENZ Stock Holding History

Blue Clay Capital Management’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-100,000	Closed	-$317K	–	124
2015 Q3	$317K	Buy	+100,000	New	+$303K	0.25%	76
2015 Q1	–	Sell	-186,900	Closed	-$830K	–	79
2014 Q4	$830K	Buy	+186,900	New	+$891K	0.61%	43

Other funds holding ENZ

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

LSVM

Lone Star Value Management Old Greenwich, Connecticut $52.7M AUM 30.18% 1-Year Est. Return

KIA

Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return

Blue Clay Capital Management's ENZ Position: Q4 2015 in Review

Blue Clay Capital Management sold out of Enzo Biochem, Inc. (ENZ) in Q4 2015, closing a stake of 100,000 shares — an estimated $317K sold.

Blue Clay Capital Management first reported a position in ENZ in Q4 2014 and held it in 2 quarters. The position peaked at $830K in Q4 2014. 89 funds tracked by Wall St. Rank hold ENZ as of Q4 2015.

Blue Clay Capital Management reported no remaining Enzo Biochem, Inc. position as of Q4 2015 after selling out during the quarter.
Blue Clay Capital Management sold 100,000 Enzo Biochem, Inc. shares in Q4 2015, an estimated $317K.
Blue Clay Capital Management first reported a position in Enzo Biochem, Inc. in Q4 2014 and held it in 2 quarters.
Blue Clay Capital Management's Enzo Biochem, Inc. position peaked at $830K in Q4 2014.
89 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q4 2015.

Based on Blue Clay Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.